Oppenheimer Asset Management Inc. Boosts Stock Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Oppenheimer Asset Management Inc. grew its holdings in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 22.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,027 shares of the company's stock after acquiring an additional 2,375 shares during the period. Oppenheimer Asset Management Inc.'s holdings in Inspire Medical Systems were worth $2,415,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Inspire Medical Systems in the 3rd quarter worth $1,929,000. Thrivent Financial for Lutherans increased its position in Inspire Medical Systems by 39.7% in the third quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company's stock worth $23,337,000 after buying an additional 31,444 shares in the last quarter. Merit Financial Group LLC bought a new position in shares of Inspire Medical Systems in the fourth quarter worth about $313,000. Principal Financial Group Inc. lifted its position in shares of Inspire Medical Systems by 3,812.6% during the 3rd quarter. Principal Financial Group Inc. now owns 141,089 shares of the company's stock valued at $29,777,000 after buying an additional 137,483 shares in the last quarter. Finally, Public Employees Retirement System of Ohio grew its stake in shares of Inspire Medical Systems by 9.4% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 36,361 shares of the company's stock valued at $7,674,000 after acquiring an additional 3,125 shares during the period. Hedge funds and other institutional investors own 94.91% of the company's stock.

Remove Ads

Inspire Medical Systems Price Performance

Shares of NYSE INSP traded up $2.25 during midday trading on Thursday, reaching $178.45. 170,286 shares of the stock traded hands, compared to its average volume of 583,635. The company's 50 day moving average is $187.46 and its 200 day moving average is $192.90. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The stock has a market capitalization of $5.29 billion, a PE ratio of 103.10, a P/E/G ratio of 2.86 and a beta of 1.48.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings data on Monday, February 10th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. As a group, equities analysts forecast that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Wall Street Analyst Weigh In

INSP has been the topic of a number of recent analyst reports. Royal Bank of Canada restated an "outperform" rating and set a $260.00 target price on shares of Inspire Medical Systems in a research note on Tuesday, February 11th. Bank of America upgraded shares of Inspire Medical Systems from a "neutral" rating to a "buy" rating and raised their price objective for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Wells Fargo & Company lowered their target price on shares of Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating on the stock in a research note on Tuesday, February 11th. Morgan Stanley cut their target price on Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating for the company in a research report on Tuesday, February 11th. Finally, Robert W. Baird lowered their price target on Inspire Medical Systems from $252.00 to $248.00 and set an "outperform" rating on the stock in a report on Tuesday, February 11th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $228.82.

Insider Buying and Selling

In related news, insider Randy Ban sold 25,584 shares of the firm's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $183.50, for a total value of $4,694,664.00. Following the completion of the sale, the insider now directly owns 7,259 shares in the company, valued at $1,332,026.50. This trade represents a 77.90 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CTO John Rondoni sold 583 shares of the business's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the transaction, the chief technology officer now owns 10,424 shares in the company, valued at $1,777,187.76. This trade represents a 5.30 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 26,225 shares of company stock worth $4,806,530. Corporate insiders own 4.10% of the company's stock.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.